Tuesday, 31 January 2017

Global Allergy Immunotherapy Market Trends and Opportunities Review 2015

Scope of the Report
The report titled “Global Allergy Immunotherapy Market: Trends & Opportunities (2015-2019)” provides an in-depth analysis of the global allergy immunotherapy market with detailed analysis of market sizing and growth, market share and economic impact of the industry. Global allergy immunotherapy market penetration rate is also provided in the report. The report also provides market size of allergic rhino conjunctivitis (AR) and HDM allergy disease. The report provides detailed market share analysis of the global allergy immunotherapy market by types, regions and players. The market share of allergy immunotherapy market in the respiratory market and prescription allergy market is also explained in detailed.

Purchase a copy of Global Allergy Immunotherapy Market visit @  http://www.orbisresearch.com/contact/purchase/185314 For more information contact sales@orbisresearch.com   .

The report provides detail regional analysis of the allergy immunotherapy market in the United States and Europe. In regional analysis market by value, key players are provided with market for pipeline products.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy industry has also been forecasted for the period 2014-2019, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition is global allergy immunotherapy market is stiff and dominated by the big players like ALK-Abello. Further, key players of the allergy immunotherapy industry like ALK-Abello, Stallergenes; and Allergy Therapeutics are also profiled with their financial information and respective business strategies.


Country Coverage
United States
Europe

Company Coverage
ALK-Abello
Stallergenes
Allergy Therapeutics

Executive Summary

Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. Allergy shots decrease sensitivity to allergens that’s why it is known as “desensitization or hypo-sensitization” and often lead to lasting relief of allergy symptoms even after treatment is stopped. This makes it a cost-effective, beneficial treatment approach for many people. Allergen immunotherapy is a preventive treatment for allergic reactions to substances such as grass pollens, house dust mites and bee venom. Whole allergen immunotherapy is the only treatment that targets the actual cause of the allergy and attempts to re-educate the immune system to tolerate the allergen.

In the 2013 ‘World Allergy Organization White Book’, the WHO estimated that there were 400 million people in the world suffering from allergic rhinitis and 300 million from asthma, which shows the scale of the problem. The most common allergens found in the US and Europe.
Patients presenting with allergies are questioned and the tested in an attempt to ascertain exactly what they are allergic to. Once this has been identified, a treatment regime can be put in place. However, the approaches in the US and Europe are quite different, largely because of differences in product availability. The type of product used falls into three categories: SCIT, SLITD and SLITT.


Some points from List Of Tables:
Figure 1: Incidence of Allergies in the 20th Century-% of Population
Figure 2: Progression of Allergic Response
Figure 3: Inflammatory Mechanism and Effect of AIT
Figure 4: Interaction between Allergoid and Adjuvant
Figure 5: Global Allergy Immunotherapy Market by Value; 2011-2015E (US$ Million)
Figure 6: Global Allergy Immunotherapy Market by Value; 2016-2019E (US$ Million)
Figure 7: Allergy Immunotherapy Patients by Regions; 2014 (Million)
Figure 8: Allergy Immunotherapy Market Penetration Rate by Regions; 2014 (%)
Figure 9: Allergic Rhino Conjunctivitis (AR) Patients by Regions; 2014
Figure 10: HDM Allergy Disease Patients by Regions; 2014
Figure 11: Global Allergen Immunotherapy Market by Types; 2014 

For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow us on Twitter: https://twitter.com/orbisresearch


No comments:

Post a Comment